Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eaton Vance Ohio Municipal Income Trust (NQ:EVO)

3.326 +0.136 (+4.26%)
Streaming Delayed Price Updated: 11:46 AM EST, Jan 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eaton Vance Ohio Municipal Income Trust

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Evotec and Bristol Myers Squibb Expand Proteomics Partnership
Via ACCESSWIRE
News headline image
Sherwin-Williams, Apple And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Novo Nordisk And Evotec Collaborate On Stem Cell-Based Therapy Development ↗
Evotec and Novo Nordisk have partnered to develop off-the-shelf cell therapy products. The collaboration will focus on advancing stem cell-based therapies for potential commercialization. 
Via Benzinga
News headline image
Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-Generation Cell Therapies
Via ACCESSWIRE
News headline image
Just - Evotec Biologics Opens Cutting-Edge Biologics Facility - J.POD(R) Toulouse, France (EU)
Via ACCESSWIRE
News headline image
FedEx Reports Downbeat Results, Joins MillerKnoll And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Evotec Announces Change in Management Board
Via ACCESSWIRE
News headline image
Evotec Announces Strong Progress in Strategic Protein Degradation Partnership with Bristol Myers Squibb
Via ACCESSWIRE
News headline image
Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery
From X-Chem
Via Business Wire
News headline image
Hain Celestial Posts Upbeat Q4 Earnings, Joins Soleno Therapeutics, Energizer Holdings And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
Bristol Myers' German Partner Evotec Plans Layoffs, Cites 'Challenging Revenues, Profitability' ↗
Evotec reports a rise in Q2 sales to $201.12M but posts an EPS loss of $0.54. CEO Christian Wojczewski cites market challenges and outlines cost-cutting measures, including a 7% workforce reduction. 
Via Benzinga
Topics Workforce
News headline image
EVO Stock Earnings: Evotec Misses EPS, Misses Revenue for Q2 2024 ↗
EVO stock results show that Evotec missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb
Via ACCESSWIRE
News headline image
Evotec SE Provides Guidance Update
Via ACCESSWIRE
News headline image
Evotec Provides Guidance Update
Via ACCESSWIRE
News headline image
Evotec SE Reports H1 2024 Results: Challenging Year; Priority Reset for Sustainable Profitable Growth Gaining Momentum, Building on Core Strengths
Via ACCESSWIRE
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
Pre-market stock movers are a hot topic on Wednesday and we have all of the latest news traders need to know about them this morning! 
Via InvestorPlace
News headline image
Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Evotec SE Reports First Half-year 2024 Results on 14 August 2024
Via ACCESSWIRE
News headline image
Evotec and Pfizer Collaborate to Advance Drug Discovery in France
Via ACCESSWIRE
News headline image
Just - Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz
Via ACCESSWIRE
News headline image
Delta Air Lines Posts Downbeat Earnings, Joins United Airlines, American Airlines And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Just - Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program
Via ACCESSWIRE
News headline image
German Drug Developer Evotec Seeks Adviser Input As Takeover Concerns Mount ↗
Evotec consults defense advisers following a significant share price decline, raising concerns about a potential takeover. 
Via Benzinga
News headline image
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
AMC Networks, Louisiana-Pacific And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb
Via ACCESSWIRE
News headline image
Evotec SE: Results of the Annual General Meeting 2024
Via ACCESSWIRE
News headline image
Evotec, Inserm, Lille University Hospital and Inserm Transfert Enter Collaboration to Identify Novel Therapeutic Targets in Obesity and Metabolic Diseases
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.